Progress, Potential, and Possibilities Podcast / Show Mineral Biology: What a Crayfish Can Teach Us About Human Health | Eden Ben - CEO, Amorphical
There’s an animal that can rebuild its entire body structure in just a few days—and it might hold clues to a new kind of medicine.
Eden Ben is CEO of Amorphical ( https://www.amorphical.com/ ), a pioneering biotech company out of Israel that’s been quietly building a completely new approach to mineral-based therapeutics.
Founded in 2004, Amorphical has developed a proprietary nano-formulation of amorphous calcium carbonate—what they call ACC—engineered using biomimicry principles inspired by how certain organisms naturally stabilize calcium in highly bioavailable forms.
What makes this so interesting is that ACC behaves very differently from traditional crystalline calcium. It’s dramatically more soluble, significantly more bioavailable, and appears to act not just as a supplement, but as a functional, bioactive material that can influence cellular and tissue-level processes.
The company is leveraging this platform across a range of indications—from bone and metabolic diseases to inflammatory conditions—aiming to move beyond symptom management and toward addressing underlying biological mechanisms.
Eden himself has had a fascinating journey with the company—from early business development and global market expansion, to leading clinical and product strategy, and now stepping into the CEO role to scale both the science and the business globally.
#Biotech #Longevity #Geroscience #Calcium #Nanotechnology #Biomimicry #ExtracellularMatrix #CancerResearch #Inflammation #Osteoporosis #BoneHealth #FutureOfMedicine #LifeSciences #Biology #RegenerativeMedicine #HealthInnovation #StartupScience #DeepTech #MedicalBreakthrough #Podcast #SciencePodcast #IsraeliInnovation #NanoMedicine #AgingResearch